Amgen Boosts Bid for Onyx to $130 a Share

Aug. 7 (Bloomberg) -- Amgen, the drugmaker in pursuit of Onyx Pharmaceuticals, boosted its offer for the company to $130 a share, according to a person familiar with the matter. Cristina Alesci reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Trump Jostles Montenegro Leader at NATO Meeting
01:12 - U.S. President Donald Trump was caught on camera jostling Montenegrin Prime Minister Dusko Markovic out of the way at the North Atlantic Treaty Organization meeting in Brussels on Thursday. (Excerpt. Source: APTN) (Source: Bloomberg)
  • Ian Bremmer Says Impeachment Likely Soon in Brazil
  • Trump's G-7 Debut Comes With Slap of German Trade
  • Bremmer Says Merkel-Trump Relationship 'Badly Damaged'